Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Every word you type has to appear somewhere in the question, and the closest matches are ranked first.

Limit to evidence status or GRADE (optional)

15,213 questions in 2,394 reviews

current versions
No studies 15,213 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
Surgical treatment vs radiological treatment
Quality of life · Varicoceles in subfertile men
Surgical or radiological treatment for varicoceles in subfertile men (2021) · Cochrane
no estimate extractedNRNo studies
Surgical treatment vs other surgical treatment
Live birth · Varicoceles in subfertile men
Surgical or radiological treatment for varicoceles in subfertile men (2021) · Cochrane
no estimate extractedNRNo studies
Surgical treatment vs other surgical treatment
Adverse events · Varicoceles in subfertile men
Surgical or radiological treatment for varicoceles in subfertile men (2021) · Cochrane
no estimate extractedNRNo studies
Surgical treatment vs other surgical treatment
Pregnancy · Varicoceles in subfertile men
Surgical or radiological treatment for varicoceles in subfertile men (2021) · Cochrane
no estimate extractedNRNo studies
Surgical treatment vs other surgical treatment
Varicocele recurrence · Varicoceles in subfertile men
Surgical or radiological treatment for varicoceles in subfertile men (2021) · Cochrane
no estimate extractedNRNo studies
Surgical treatment vs other surgical treatment
Quality of life · Varicoceles in subfertile men
Surgical or radiological treatment for varicoceles in subfertile men (2021) · Cochrane
no estimate extractedNRNo studies
Radiological treatment vs radiological treatment
Live birth · Varicoceles in subfertile men
Surgical or radiological treatment for varicoceles in subfertile men (2021) · Cochrane
no estimate extractedNRNo studies
Radiological treatment vs radiological treatment
Adverse events · Varicoceles in subfertile men
Surgical or radiological treatment for varicoceles in subfertile men (2021) · Cochrane
no estimate extractedNRNo studies
Radiological treatment vs radiological treatment
Pregnancy · Varicoceles in subfertile men
Surgical or radiological treatment for varicoceles in subfertile men (2021) · Cochrane
no estimate extractedNRNo studies
Varicocele treatment vs non‐surgical, delayed, or no treatment
Adverse events · Varicoceles in subfertile men
Surgical or radiological treatment for varicoceles in subfertile men (2021) · Cochrane
no estimate extractedNRNo studies
Radiological treatment vs radiological treatment
Quality of life · Varicoceles in subfertile men
Surgical or radiological treatment for varicoceles in subfertile men (2021) · Cochrane
no estimate extractedNRNo studies
Varicocele treatment vs non‐surgical, delayed, or no treatment
Varicocele recurrence · Varicoceles in subfertile men
Surgical or radiological treatment for varicoceles in subfertile men (2021) · Cochrane
no estimate extractedNRNo studies
Varicocele treatment vs non‐surgical, delayed, or no treatment
Quality of life · Varicoceles in subfertile men
Surgical or radiological treatment for varicoceles in subfertile men (2021) · Cochrane
no estimate extractedNRNo studies
Valvuloplasty plus surgery of the superficial venous system vs surgery of the superficial venous system
Ulcer healing and recurrence · people with non‐severe primary valvular incompetence
Surgery for deep venous insufficiency (2021) · Cochrane
no estimate extractedNRNo studies
Prophylactic CPAP vs very early CPAP
Failed treatment · preterm infants
Prophylactic or very early initiation of continuous positive airway pressure (CPAP) for preterm infants (2021) · Cochrane
no estimate extractedNRNo studies
Prophylactic CPAP vs very early CPAP
Combined outcome of death and bronchopulmonary dysplasia · preterm infants
Prophylactic or very early initiation of continuous positive airway pressure (CPAP) for preterm infants (2021) · Cochrane
no estimate extractedNRNo studies
Prophylactic CPAP vs very early CPAP
Intraventricular haemorrhage grade 3 or 4 · preterm infants
Prophylactic or very early initiation of continuous positive airway pressure (CPAP) for preterm infants (2021) · Cochrane
no estimate extractedNRNo studies
Prophylactic CPAP vs very early CPAP
Neurodevelopmental impairment · preterm infants
Prophylactic or very early initiation of continuous positive airway pressure (CPAP) for preterm infants (2021) · Cochrane
no estimate extractedNRNo studies
Prophylactic or very early CPAP vs supportive care
Neurodevelopmental impairment · preterm infants
Prophylactic or very early initiation of continuous positive airway pressure (CPAP) for preterm infants (2021) · Cochrane
no estimate extractedNRNo studies
Oxytocin solution vs plasma expander
Maternal mortality · management of retained placenta
Umbilical vein injection for management of retained placenta (2021) · Cochrane
no estimate extractedNRNo studies
Oxytocin solution vs plasma expander
Blood transfusion · management of retained placenta
Umbilical vein injection for management of retained placenta (2021) · Cochrane
no estimate extractedNRNo studies
Oxytocin solution vs plasma expander
Additional therapeutic uterotonics · management of retained placenta
Umbilical vein injection for management of retained placenta (2021) · Cochrane
no estimate extractedNRNo studies
Oxytocin solution vs plasma expander
Need for treatment with antibiotics (infection) · management of retained placenta
Umbilical vein injection for management of retained placenta (2021) · Cochrane
no estimate extractedNRNo studies
Oxytocin solution vs plasma expander
Maternal postpartum anaemia (haemoglobin 24–48 hours postpartum) · management of retained placenta
Umbilical vein injection for management of retained placenta (2021) · Cochrane
no estimate extractedNRNo studies
Saline solution vs expectant management
Addition of therapeutic uterotonics · management of retained placenta
Umbilical vein injection for management of retained placenta (2021) · Cochrane
no estimate extractedNRNo studies
Medical or surgical intervention, or both, for gastro‐oesophageal reflux disease vs nil intervention, delayed intervention control, or placebo
Healthcare utilisation ‐ not measured · treatment for asthma in adults and children with asthma and GORD
Pharmacological and surgical interventions for the treatment of gastro‐oesophageal reflux in adults and… (2021) · Cochrane
no estimate extractedNRNo studies
Antenatal (± postnatal) prophylaxis: heparin (LMWH or UFH) vs no treatment/placebo
Maternal death · pregnant women at increased risk of VTE during pregnancy and the early postnatal period
Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period (2021) · Cochrane
no estimate extractedNRNo studies
Peripartum/postnatal prophylaxis: UFH vs no treatment
Maternal death · women with varicose veins before birth, having a caesarean (elective or emergency) or vaginal birth
Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period (2021) · Cochrane
no estimate extractedNRNo studies
Peripartum/postnatal prophylaxis: UFH vs no treatment
Adverse effects sufficient to stop treatment · women with varicose veins before birth, having a caesarean (elective or emergency) or vaginal birth
Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period (2021) · Cochrane
no estimate extractedNRNo studies
Peripartum/postnatal prophylaxis (caesarean): LMWH vs UFH
Maternal death · women giving birth by elective or emergency caesarean (elective or emergency (1 trial), elective cesarean only (1…
Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period (2021) · Cochrane
no estimate extractedNRNo studies
Peripartum/postnatal prophylaxis (caesarean): LMWH vs UFH
Adverse effects sufficient to stop treatment · women giving birth by elective or emergency caesarean (elective or emergency (1 trial), elective cesarean only (1…
Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period (2021) · Cochrane
no estimate extractedNRNo studies
Postnatal prophylaxis: LMWH vs no treatment/placebo
Adverse effects sufficient to stop treatment · women at increased risk of VTE in the early postpartum period
Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period (2021) · Cochrane
no estimate extractedNRNo studies
Antenatal (± postnatal) prophylaxis: LMWH vs UFH
Maternal death · pregnant women at increased risk of VTE during pregnancy and the early postnatal period
Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period (2021) · Cochrane
no estimate extractedNRNo studies
Foam sclerotherapy vs foam sclerotherapy
QoL · participants with varicose veinsa
Injection sclerotherapy for varicose veins (2021) · Cochrane
no estimate extractedNRNo studies
Foam sclerotherapy vs foam sclerotherapy
Persistence of symptoms · participants with varicose veinsa
Injection sclerotherapy for varicose veins (2021) · Cochrane
no estimate extractedNRNo studies
Foam sclerotherapy vs liquid sclerotherapy
Complications ‐ DVT · participants with varicose veinsa
Injection sclerotherapy for varicose veins (2021) · Cochrane
no estimate extractedNRNo studies
Foam sclerotherapy vs liquid sclerotherapy
QoL · participants with varicose veinsa
Injection sclerotherapy for varicose veins (2021) · Cochrane
no estimate extractedNRNo studies
Foam sclerotherapy vs liquid sclerotherapy
Persistence of symptoms · participants with varicose veinsa
Injection sclerotherapy for varicose veins (2021) · Cochrane
no estimate extractedNRNo studies
Sclerotherapy vs sclerotherapy with different substances
Cosmetic appearance · participants with varicose veinsb
Injection sclerotherapy for varicose veins (2021) · Cochrane
no estimate extractedNRNo studies
Sclerotherapy vs sclerotherapy with different substances
Complications ‐ DVT · participants with varicose veinsb
Injection sclerotherapy for varicose veins (2021) · Cochrane
no estimate extractedNRNo studies
Sclerotherapy vs sclerotherapy with different substances
Residual varicose veins · participants with varicose veinsb
Injection sclerotherapy for varicose veins (2021) · Cochrane
no estimate extractedNRNo studies
Sclerotherapy vs sclerotherapy with different substances
QoL · participants with varicose veinsb
Injection sclerotherapy for varicose veins (2021) · Cochrane
no estimate extractedNRNo studies
Sclerotherapy vs sclerotherapy with different substances
Persistence of symptoms · participants with varicose veinsb
Injection sclerotherapy for varicose veins (2021) · Cochrane
no estimate extractedNRNo studies
Sclerotherapy vs sclerotherapy with different substances
Recurrent varicose veins · participants with varicose veinsb
Injection sclerotherapy for varicose veins (2021) · Cochrane
no estimate extractedNRNo studies
Foam sclerotherapy vs placebo
Recurrent varicose veins · participants with varicose veinsa
Injection sclerotherapy for varicose veins (2021) · Cochrane
no estimate extractedNRNo studies
Passive information provision vs control
Positive mental well‐being · stroke survivors
Information provision for stroke survivors and their carers (2021) · Cochrane
no estimate extractedNRNo studies
Passive information provision vs control
Anxiety (cases) ‐ not measured · stroke carers
Information provision for stroke survivors and their carers (2021) · Cochrane
no estimate extractedNRNo studies
Passive information provision vs control
Depression (cases) ‐ not measured · stroke carers
Information provision for stroke survivors and their carers (2021) · Cochrane
no estimate extractedNRNo studies
Passive information provision vs control
Positive mental well‐being · stroke carers
Information provision for stroke survivors and their carers (2021) · Cochrane
no estimate extractedNRNo studies
Passive information provision vs control
Quality of life ‐ not measured · stroke carers
Information provision for stroke survivors and their carers (2021) · Cochrane
no estimate extractedNRNo studies